Compare IKNA & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The company makes it possible for its clients to increase revenues, improve customer service, and increase operational efficiencies. Under the new direction, the company is focused on partnering with banks credit card issuers, and retailers to prevent fraud. It derives revenue through Sales of systems, subscription fees, Sale of software upgrades, and extended maintenance programs.